Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Itraconazole on CRD-740 Pharmacokinetics in Healthy Adults
NCT05437094Phase 1Completed
- Sponsor
- Cardurion Pharmaceuticals
- Start
- Jun 2022
- Primary completion
- Aug 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of edelinontrine in heart failure (HF) (2 arms), sponsored by Cardurion Pharmaceuticals. Primary endpoints: Area under the concentration-time curve from time zero to 24 hours, Area under the concentration-time curve from time zero to infinity at Day 16 and 2 more. Started Jun 2022; status: completed.
02
Drugs
edelinontrine
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT05437094.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05437094.